This site provides INTERCEPT product information for International audiences Select your region
TA-GVHD Consequences for Transfused Patient
TA-GVHD can damage organs such as bone marrow, skin, liver and the gastrointestinal tract. TA-GVHD survival is rare with a mortality rate approaching 100%, with death typically occurring within the first three weeks of symptoms. With this high mortality rate, and the lack of an effective treatment for TA-GVHD, it is critical that TA-GVHD be prevented where possible.